Mendelian randomization demonstrates a causal link between peripheral circulating acylcarnitines and intracranial

Ying Wang1, Kang Xie1, Junyu Wang1

  • 1Department of Neurosurgery, National Clinical Research Center of Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, 410008, China.

Insights

Specific blood metabolites, including palmitoylcarnitine, stearoylcarnitine, and 2-tetradecenoylcarnitine, are causally linked to intracranial aneurysms (IAs) and their rupture. Hypertension partially mediates this relationship.

Area of Science:

  • Cardiovascular Science
  • Metabolomics
  • Genetics

Background:

  • Intracranial aneurysms (IAs) are a leading cause of subarachnoid hemorrhage (SAH), characterized by vascular remodeling.
  • The precise triggers for IA development and rupture remain unclear.
  • Abnormalities in circulating proteins and metabolites have been observed in IA patients.

Purpose of the Study:

  • To investigate the potential causal relationship between peripheral circulating metabolites and proteins and intracranial aneurysms (IAs).
  • To explore the mediating role of hypertension in the association between specific metabolites and IAs.

Main Methods:

  • Utilized two-sample Mendelian randomization (MR) analysis.
  • Analyzed data from the FinnGen study and published GWAS datasets.
  • Included 191 blood metabolites and 1398 proteins in the analysis.

Main Results:

  • Identified palmitoylcarnitine, stearoylcarnitine, and 2-tetradecenoylcarnitine as causal contributors to IAs and their ruptures.
  • Two-step mediation MR analysis indicated that hypertension mediates the causal link between these metabolites and IAs.

Conclusions:

  • Blood metabolites palmitoylcarnitine, stearoylcarnitine, and 2-tetradecenoylcarnitine are causally associated with IA formation and rupture.
  • Hypertension plays a partial mediating role in this causal pathway.